Wyeth Premarin Biannual Price Increases To Boost "Cheap" 60[cents] Daily Cost

Wyeth-Ayerst will adopt a biannual price increase strategy for the hormone replacement therapy Premarin, the company told analysts during its second quarter earnings call July 24.